KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues

KRAS mutation has been unambiguously identified as a marker of resistance to cetuximab-based treatment in metastatic colorectal cancer (mCRC) patients. However, most studies of KRAS mutation analysis have been performed using homogenously archived CRC specimens, and studies that compare freshly froz...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Solassol, Jérome, Ramos, Jeanne, Crapez, Evelyne, Saifi, Majda, Mangé, Alain, Vianès, Evelyne, Lamy, Pierre-Jean, Costes, Valérie, Maudelonde, Thierry
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Molecular Diversity Preservation International (MDPI) 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3116185/
https://ncbi.nlm.nih.gov/pubmed/21686179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms12053191
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg